Search results
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 8 hours agoTrulicity had $1.46 billion in first-quarter sales, down 26% and below the $1.63 billion Street...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC Universal via AOL· 6 days agoBy attaching a chemotherapy drug to an antibody, doctors are able to deliver more potentcancer...
VCU Massey Cancer Center research reveals mechanism behind cancer drug resistance
WRIC 8 News Richmond· 3 days agoResearchers at Virginia Commonwealth University’s (VCU) Massey Comprehensive Cancer Center have...
Cancer patients often do better with less intensive treatment, new research finds
seattlepi.com· 6 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Breakthroughs in Breast Cancer: Susan G. Komen(R) | Newswise
Newswise· 2 days agoScholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization, showcased cutting-edge breast
Gamechanging blood test predicts breast cancer relapse up to three years early
Daily Express· 6 days agoAn “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 4 days agoJackson Lee, a Democrat representing Texas, said that she is “currently undergoing treatment to...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 3 days agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
Red Flags for Early-Onset Colorectal Cancer Identified
Medscape· 4 days agoThe most common presenting signs and symptoms of early-onset colorectal cancer include rectal...
A drug that prolongs the survival of 67% of patients
Hardwood Paroxysm· 5 days agoFor this reason, the International Breast Cancer Center – Pangea Oncology (IBCC), in Barcelona, has been studying for three years the approach to...